Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

BACKGROUND: The recombinant vesicular stomatitis virus (rVSV) vaccine expressing the Zaire Ebola virus (ZEBOV) glycoprotein is efficacious in the weeks following single-dose injection, but duration of immunity is unknown. We aimed to assess antibody persistence at 1 and 2 years in volunteers who rec...

詳細記述

保存先:
書誌詳細
出版年:Lancet Infect Dis
主要な著者: Huttner, Angela, Agnandji, Selidji Todagbe, Combescure, Christophe, Fernandes, José F, Bache, Emmanuel Bache, Kabwende, Lumeka, Ndungu, Francis Maina, Brosnahan, Jessica, Monath, Thomas P, Lemaître, Barbara, Grillet, Stéphane, Botto, Miriam, Engler, Olivier, Portmann, Jasmine, Siegrist, Denise, Bejon, Philip, Silvera, Peter, Kremsner, Peter, Siegrist, Claire-Anne
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6408946/
https://ncbi.nlm.nih.gov/pubmed/29627147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(18)30165-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料